NGA
GSK icon

Naples Global Advisors’s GSK GSK Stock Holding History

Naples Global Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09M Sell
39,435
-749
-2% -$39.6K 0.13% 166
2026
Q1 		$2.24M Buy
40,184
+135
+0.3% +$7.32K 0.16% 153
2025
Q4 		$1.98M Sell
40,049
-370
-0.9% -$17.3K 0.15% 164
2025
Q3 		$1.76M Buy
40,419
+338
+0.8% +$13.2K 0.14% 174
2025
Q2 		$1.56M Sell
40,081
-1,125
-3% -$43K 0.13% 176
2025
Q1 		$1.61M Sell
41,206
-1,900
-4% -$69.6K 0.15% 172
2024
Q4 		$1.48M Sell
43,106
-3,153
-7% -$114K 0.14% 178
2024
Q3 		$1.91M Sell
46,259
-565
-1% -$23.1K 0.18% 154
2024
Q2 		$1.82M Sell
46,824
-1,670
-3% -$70.2K 0.18% 149
2024
Q1 		$2.1M Buy
48,494
+320
+0.7% +$13.2K 0.21% 132
2023
Q4 		$1.8M Sell
48,174
-630
-1% -$22.6K 0.2% 141
2023
Q3 		$1.79M Sell
48,804
-360
-0.7% -$12.8K 0.22% 127
2023
Q2 		$1.77M Buy
49,164
+860
+2% +$30.8K 0.21% 140
2023
Q1 		$1.73M Buy
48,304
+4,000
+9% +$140K 0.22% 141
2022
Q4 		$1.57M Buy
44,304
+3,323
+8% +$111K 0.2% 156
2022
Q3 		$1.22M Sell
40,981
-1,011
-2% -$38.3K 0.17% 174
2022
Q2 		$2.3M Buy
41,992
+5,346
+15% +$295K 0.3% 107
2022
Q1 		$2M Buy
36,646
+414
+1% +$22.5K 0.23% 135
2021
Q4 		$2M Buy
36,232
+11
+0% +$572 0.23% 132
2021
Q3 		$1.73M Sell
36,221
-1,543
-4% -$77.5K 0.23% 135
2021
Q2 		$1.88M Buy
37,764
+1,767
+5% +$84.9K 0.26% 119
2021
Q1 		$1.61M Sell
35,997
-854
-2% -$38.8K 0.24% 125
2020
Q4 		$1.7M Buy
36,851
+1,605
+5% +$73.7K 0.29% 106
2020
Q3 		$1.66M Buy
35,246
+2,125
+6% +$106K 0.32% 93
2020
Q2 		$1.69M Buy
33,121
+4,467
+16% +$229K 0.36% 84
2020
Q1 		$1.36M Buy
28,654
+4
+0% +$213 0.36% 85
2019
Q4 		$1.68M Buy
28,650
+475
+2% +$26.4K 0.35% 88
2019
Q3 		$1.5M Buy
28,175
+1,340
+5% +$68.9K 0.35% 89
2019
Q2 		$1.34M Buy
26,835
+40
+0.1% +$2.01K 0.33% 98
2019
Q1 		$1.4M Buy
26,795
+1,274
+5% +$63.7K 0.36% 91
2018
Q4 		$1.26M Buy
25,521
+3,306
+15% +$163K 0.36% 92
2018
Q3 		$1.11M Buy
22,215
+1,944
+10% +$98.8K 0.3% 115
2018
Q2 		$1.02M Buy
20,271
+1,740
+9% +$87.6K 0.29% 121
2018
Q1 		$905K Buy
18,531
+1,400
+8% +$65.2K 0.27% 128
2017
Q4 		$760K Sell
17,131
-5,148
-23% -$238K 0.22% 153
2017
Q3 		$1.13M Buy
22,279
+420
+2% +$21.3K 0.38% 92
2017
Q2 		$1.18M Buy
21,859
+504
+2% +$26.9K 0.42% 84
2017
Q1 		$1.13M Buy
21,355
+200
+0.9% +$10.1K 0.4% 90
2016
Q4 		$1.02M Sell
21,155
-92
-0.4% -$4.54K 0.4% 94
2016
Q3 		$1.15M Buy
21,247
+600
+3% +$32.9K 0.45% 82
2016
Q2 		$1.12M Buy
20,647
+452
+2% +$23.8K 0.46% 79
2016
Q1 		$1.02M Sell
20,195
-480
-2% -$23.9K 0.43% 88
2015
Q4 		$1.04M Buy
20,675
+452
+2% +$23K 0.51% 74
2015
Q3 		$972K Buy
20,223
+540
+3% +$28.1K 0.5% 76
2015
Q2 		$1.02M Buy
19,683
+1,052
+6% +$59.2K 0.49% 79
2015
Q1 		$1.07M Buy
18,631
+440
+2% +$25.2K 0.51% 78
2014
Q4 		$972K Buy
18,191
+2,416
+15% +$135K 0.51% 81
2014
Q3 		$907K Buy
15,775
+4,388
+39% +$269K 0.53% 72
2014
Q2 		$761K Buy
11,387
+1,161
+11% +$78.6K 0.45% 86
2014
Q1 		$683K Buy
10,226
+528
+5% +$35.7K 0.42% 92
2013
Q4 		$647K Buy
+9,698
New +$629K 0.43% 92

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Naples Global Advisors's GSK Position: Q2 2026 in Review

Naples Global Advisors reduced its GSK (GSK) stake by 1.9% in Q2 2026, selling an estimated $39.6K and leaving 39,435 shares worth $2.09M. The position accounts for 0.13% of the portfolio, ranked #166.

Naples Global Advisors first reported a position in GSK in Q4 2013 and has held it in 51 quarters since. The position peaked at $2.3M in Q2 2022. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Naples Global Advisors held 39,435 shares of GSK worth $2.09M as of Q2 2026.
  • Naples Global Advisors sold 749 GSK shares in Q2 2026, an estimated $39.6K.
  • GSK made up 0.13% of Naples Global Advisors's portfolio in Q2 2026, its #166 holding.
  • Naples Global Advisors first reported a position in GSK in Q4 2013 and has held it in 51 quarters since.
  • Naples Global Advisors's GSK position peaked at $2.3M in Q2 2022.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Naples Global Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.